1-5 of 5
Katy Rezvani, MBBS, PhD, MRCP, FRCPath
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Can the Combination of the Measurement of BCR-ABL1 Transcript Levels At 3 and 6 Months Improve the Prognostic Value of the 3 Month Measurement?

Free
Pratap Neelakantan, MRCP, Gareth Gerrard, PhD, Letizia Foroni, Dragana Milojkovic, Jane Apperley, Richard Szydlo, PhD, Marco Bua, Alistair G Reid, BSc, PhD, Katy Rezvani, MBBS, PhD, MRCP, FRCPath, John M Goldman, MD, David Marin
Journal: Blood
Blood (2012) 120 (21): 68.
https://doi.org/10.1182/blood.V120.21.68.68
Published: 2012
Journal Articles

Is Major Molecular Response a Safe Haven Against Blast Crisis in Cml Patients Treated with Imatinib?

Free
Pratap Neelakantan, MRCP, Dragana Milojkovic, Gareth Gerrard, PhD, Letizia Foroni, Jane Apperley, Richard M Szydlo, Alistair Reid, PhD, Marco Bua, Katy Rezvani, MBBS, PhD, MRCP, FRCPath, John M Goldman, MD, David Marin
Journal: Blood
Blood (2012) 120 (21): 3760.
https://doi.org/10.1182/blood.V120.21.3760.3760
Published: 2012
Journal Articles

Thrombopoietic Agonists Show Efficacy in ITP Related to Allogeneic Stem Cell Transplantation,

Free
Emma M O'Donovan, MBBS BSc MRCP MRCPath, Katy Rezvani, MBBS, PhD, MRCP, FRCPath, Jeremy Sargent, MD, MRCP, FRCPath, Deborah Richardson, MD, FRCP, FRCPath, MA, MBBChir, Hannah Tharmalingam, Paul Veys, MD MRCP FRCPath, Jane F Apperley, MBChB, MD, FRCP, FRCPath, Nichola Cooper, MA MD MRCP FRCPath
Journal: Blood
Blood (2011) 118 (21): 3292.
https://doi.org/10.1182/blood.V118.21.3292.3292
Published: 2011
Journal Articles

Prolonged Survival Following Imatinib Failure for CML Patients in CP May Require Multiple TKI Strategies for Responding Patients,

Free
Dragana Milojkovic, MD, Jane F Apperley, MBChB, MD, FRCP, FRCPath, Amr R Ibrahim, Marco Bua, MD, Alistair Reid, PhD, Gareth Gerrard, PhD, Letizia Foroni, MD PhD, Katy Rezvani, MBBS, PhD, MRCP, FRCPath, John M Goldman, David Marin
Journal: Blood
Blood (2011) 118 (21): 3777.
https://doi.org/10.1182/blood.V118.21.3777.3777
Published: 2011
Journal Articles

Assessment of BCR-ABL1 Transcript Levels At 3 Months Is the Only Requirement for Predicting Outcome for Patients with Chronic Myeloid Leukemia Treated with Imatinib

Free
Dragana Milojkovic, MD, Amr R Ibrahim, Letizia Foroni, MD PhD, Claire Lucas, Gareth Gerrard, PhD, Lihui Wang, Richard M Szydlo, Richard E Clark, Jane F Apperley, MBChB, MD, FRCP, FRCPath, Marco Bua, MD, Jiri Pavlu, Christos Paliompeis, Alistair Reid, PhD, Katy Rezvani, MBBS, PhD, MRCP, FRCPath, John M Goldman, David Marin
Journal: Blood
Blood (2011) 118 (21): 1680.
https://doi.org/10.1182/blood.V118.21.1680.1680
Published: 2011